Introduction and Rationale

  • Phoenix Sepsis Score (PSS) derives from the 2024 Phoenix Criteria, translating adult Sepsis-3 principles to pediatric populations.
  • Permanently replaces the 2005 International Pediatric Sepsis Consensus Conference (IPSCC) definitions that relied on Systemic Inflammatory Response Syndrome (SIRS).
  • SIRS criteria were highly sensitive but lacked specificity, triggering massive over-diagnosis, alert fatigue, and unnecessary antibiotic administration in benign viral illnesses.
  • PSS focuses exclusively on life-threatening organ dysfunction caused by a dysregulated host response to infection.

Diagnostic Criteria

  • Pediatric Sepsis: Suspected or confirmed infection accompanied by a PSS of 2 points or higher.
  • Pediatric Septic Shock: Sepsis criteria fulfilled (PSS >= 2) alongside at least 1 point specifically in the cardiovascular domain of the PSS.
  • Completely eliminates redundant and outdated terminology such as severe sepsis.

Organ Dysfunction Domains

  • Evaluates organ dysfunction strictly across four physiological systems.
  • Excludes liver and renal criteria utilized in adult SOFA scores due to poor mortality predictability in pediatric cohorts.
DomainPoint AllocationEvaluated Clinical Parameters
Respiratory0-3 PointsPaO2/FiO2 ratio, SpO2/FiO2 ratio, requirement for invasive or non-invasive mechanical ventilation.
Cardiovascular0-6 PointsAge-adjusted severe hypotension, blood lactate concentrations (> 5 mmol/L scores high), requirement for vasoactive medications.
Coagulation0-3 PointsPlatelet count (< 100,000/µL), INR, Fibrinogen levels, D-dimer levels.
Neurologic0-3 PointsGlasgow Coma Scale (GCS) or AVPU score, pupil reactivity.

Clinical and Prognostic Significance

  • Developed utilizing machine learning algorithms on over 3.6 million pediatric electronic health records globally.
  • PSS >= 2 correlates directly with an in-hospital mortality rate of 7.1% in higher-resource settings, reaching up to 28.5% in resource-limited settings (RLS).
  • Septic shock classification carries a profound mortality risk ranging from 10.8% to 33.5%.
  • Identifies 20-30% more high-risk cases previously labeled as severe sepsis while simultaneously reducing false positive diagnoses.
  • Real-world clinical implementation links PSS-guided bundles to a 15-20% reduction in overall mortality.

Guideline Integration and Indian Implementation

  • Fully adopted by the Society of Critical Care Medicine (SCCM) and Surviving Sepsis Campaign (SSC) 2026 International Guidelines.
  • Endorsed by the Indian Academy of Pediatrics (IAP) Intensive Care Chapter (2025-2026) and incorporated into Ministry of Health and Family Welfare (MoHFW) and Indian Council of Medical Research (ICMR) Standard Treatment Workflows.
  • Supports vital RLS adaptations for Indian district hospitals, authorizing the use of clinical signs (e.g., capillary refill time, clinical hypotension) when advanced laboratory access remains restricted.